Don't Quit on Danaher Stock After Horrific Earnings Reaction
Danaher's revenue outlook cut, biotech miss overshadow profit forecast raise
Danaher Posts Q2 Results, Joins Calix, Equifax And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
The Healthcare M&A Wave